Human Molecular Genetics Advance Access published online on September 19, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm275
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Succinate Inhibition of
-Ketoglutarate-Dependent Enzymes in a Yeast Model of Paraganglioma
Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First St, SW, Rochester, MN 55905, USA
* Author to whom correspondence should be addressed. Tel: +1 507 284 9041; Fax: +1 507 284 2053; Email: maher{at}mayo.edu
Received August 8, 2007; Revised September 14, 2007; Accepted September 14, 2007
The tricarboxylic acid (TCA) cycle enzyme succinate dehydrogenase (SDH) is a tumor suppressor. Heterozygosity for defective SDH subunit genes predisposes to familial paraganglioma (PGL) or pheochromocytoma (PHEO). Models invoking reactive oxygen species (ROS) or succinate accumulation have been proposed to explain the link between TCA cycle dysfunction and oncogenesis. Here we study the biochemical consequences of a common familial PGL-linked mutation, loss of the SDHB subunit, in a yeast model. This strain has increased ROS production but no evidence of mutagenic DNA damage. Because the strain lacks SDH activity, succinate accumulates dramatically and inhibits
-ketoglutarate (
KG) dependent enzyme Jlp1, involved in sulfur metabolism, and
KG-dependent histone demethylase Jhd1. We show that mammalian JmjC-domain histone demethylases (JHDMs) are also vulnerable to succinate inhibition in vitro and in cultured cells. Our results suggest that any
KG-dependent enzyme is a potential target of accumulated succinate in oncogenesis. The possible role that inhibition of these enzymes by succinate may have in oncogenesis is discussed.